 |
|
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
Jung Gil Park, Soo Young Park
Clin Mol Hepatol. 2015;21(3):242-248. Published online 2015 Sep 30 DOI: https://doi.org/10.3350/cmh.2015.21.3.242
|
|
Citations to this article as recorded by
 Tenofovir plus entecavir combination therapy for chronic hepatitis B with nucleos(t)ide analogue failure
Bengü TATAR, Şükran KÖSE
The European Research Journal.2020; 6(4): 270. CrossRef Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
Clinical and Molecular Hepatology.2020; 26(3): 352. CrossRef Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clinical and Molecular Hepatology.2016; 22(2): 238. CrossRef
|